Goldman Sachs
MIST icon

Goldman Sachs’s Milestone Pharmaceuticals MIST Stock Holding History

Goldman Sachs’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,000,025
Closed -$2.38M – 6838
2026
Q1 		$2.38M Buy
+2,000,025
New +$3.5M ﹤0.01% 4381
2025
Q4 		– Sell
-356,567
Closed -$713K – 6680
2025
Q3 		$713K Buy
356,567
+237,118
+199% +$417K ﹤0.01% 5280
2025
Q2 		$232K Buy
+119,449
New +$159K ﹤0.01% 5585
2025
Q1 		– Sell
-942,407
Closed -$2.22M – 6291
2024
Q4 		$2.22M Sell
942,407
-410,660
-30% -$705K ﹤0.01% 4185
2024
Q3 		$2.06M Hold
1,353,067
– – ﹤0.01% 4130
2024
Q2 		$1.79M Hold
1,353,067
– – ﹤0.01% 4006
2024
Q1 		$2.42M Hold
1,353,067
– – ﹤0.01% 3729
2023
Q4 		$2.26M Sell
1,353,067
-1,205,657
-47% -$3.27M ﹤0.01% 3828
2023
Q3 		$7.93M Buy
2,558,724
+3,437
+0.1% +$10.7K ﹤0.01% 2588
2023
Q2 		$7.28M Buy
2,555,287
+2,822
+0.1% +$10.6K ﹤0.01% 2763
2023
Q1 		$10.1M Sell
2,552,465
-94,651
-4% -$346K ﹤0.01% 2414
2022
Q4 		$10.5M Buy
2,647,116
+2,542,619
+2,433% +$13.4M ﹤0.01% 2538
2022
Q3 		$960K Buy
104,497
+92,493
+771% +$702K ﹤0.01% 4541
2022
Q2 		$74K Hold
12,004
– – ﹤0.01% 5941
2022
Q1 		$77K Hold
12,004
– – ﹤0.01% 6179
2021
Q4 		$79K Hold
12,004
– – ﹤0.01% 6184
2021
Q3 		$69K Hold
12,004
– – ﹤0.01% 5985
2021
Q2 		$66K Hold
12,004
– – ﹤0.01% 6035
2021
Q1 		$70K Sell
12,004
-10,246
-46% -$75K ﹤0.01% 5899
2020
Q4 		$149K Buy
22,250
+10,246
+85% +$68.6K ﹤0.01% 5186
2020
Q3 		$88K Buy
+12,004
New +$86K ﹤0.01% 5110

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Goldman Sachs's MIST Position: Q2 2026 in Review

Goldman Sachs sold out of Milestone Pharmaceuticals (MIST) in Q2 2026, closing a stake of 2,000,025 shares — an estimated $2.38M sold.

Goldman Sachs first reported a position in MIST in Q3 2020 and held it in 21 quarters. The position peaked at $10.5M in Q4 2022. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Goldman Sachs reported no remaining Milestone Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Goldman Sachs sold 2,000,025 Milestone Pharmaceuticals shares in Q2 2026, an estimated $2.38M.
  • Goldman Sachs first reported a position in Milestone Pharmaceuticals in Q3 2020 and held it in 21 quarters.
  • Goldman Sachs's Milestone Pharmaceuticals position peaked at $10.5M in Q4 2022.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.